Abstract. have been identified as oncogenes and confirmed to be overexpressed in various types of cancer. However, the regulation mechanism of miR-221/222 in oral squamous cell carcinoma (OSCC) remains to be fully elucidated. Previously, an miR-221/222 sponge was successfully constructed and its effect on the downregulation of miR-221/222 expression was investigated. In the present study, the dual luciferase reporter assay revealed a phosphatase and tensin homolog (PTEN) deletion on chromosome 10 to be a target gene of miR-221/222. It was also demonstrated that miR-221/222 suppression by transfection with an miR-221/222 sponge in vitro resulted in upregulation of PTEN. Notably, the proliferation and invasiveness of the miR-221/222 sponge-transfected cells was significantly inhibited, while apoptosis was promoted, when determined by Cell Counting Kit-8, Transwell assays and flow cytometry. The results of the present study prove that miR-221/222 may downregulate the expression of PTEN in OSCC cells and function as oncogenes, providing a novel insight into the underlying mechanism of OSCC tumorigenesis. The present study suggests that upregulating the expression of PTEN by downregulation of miR-221/222 may be a potential treatment for OSCC.
Introduction
MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene expression by binding to the 3'untranslated region (3'UTR) of target mRNAs (1, 2) . There is emerging evidence that miRNAs function as oncogenes or tumor suppressors through interaction with a number of the signal transduction pathways involved in transformation and carcinogenesis (3) (4) (5) . miRNA-221/222 (miR-221/222) are located in tandem on the X chromosome and have been reported as oncogenic miRNAs in multiple types of advanced cancer (6) (7) (8) (9) . A number of studies have observed overexpression of miR-221/222 in malignancies and the available data suggest that miR-221/222 may become suitable targets for cancer treatment (7) (8) (9) .
The miRNA sponge method was introduced in 2007 by Ebert et al (10) ; it is used to create RNAs containing multiple tandem binding sites complementary to the miRNAs of interest and leads to continuous loss of miRNA function in cells and transgenic organisms. The miRNA sponge has proven to be a valuable tool for miRNA loss of function experimental systems (11) . In a previous study, a miR-221/222 sponge was successfully constructed and its inhibitory effects on miR-221/222 in oral squamous cell carcinoma (OSCC) cells were investigated (12) .
Phosphatase and tensin homolog (PTEN) is a tumor suppressor gene that is frequently mutated in many types of cancer (13) (14) (15) (16) . PTEN expression is downregulated in a wide range of malignancies, including glioblastoma, pancreatic cancer, colorectal carcinoma, breast cancer and OSCC (13, 14, (16) (17) (18) (19) (20) . The phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway is involved in multiple biological processes, including cellular apoptosis, cell cycle regulation, survival and proliferation (21) . Previous studies have demonstrated that aberrant activation of the PI3K/Akt signaling pathway has a significant role in tumorigenesis and tumor metastasis (14) . PTEN functions as a tumor suppressor by negatively regulating the PI3K/Akt signaling pathway (22 reported to regulate the expression of PTEN (19, 23) . However, little is known about the roles of miR-221/222 in the expression of PTEN in OSCC.
In the present study, bioinformatics analysis revealed that the PTEN gene may be a direct target of miR-221/222. Binding sites for miR-221/222 were identified in the 3'UTR of PTEN using miRanda (http://www.microrna.org/) and the result is shown in Fig. 1A . miR-221/222 were identified as potent regulators of PTEN. An miR-221/222 sponge was constructed in CAL27 and HSC6 OSCC cells to validate the induction of apoptosis, and reduction of cell proliferation and invasion, through miR-221/222 inhibition and the upregulation of PTEN expression.
Materials and methods
Cells and cell culture. The 293T cell line was purchased from Land Unicomed (Guangzhou, China). The OSCC CAL27 cell line was purchased from American Type Culture Collection (ATCC; Manassas, VA, USA) and the OSCC HSC6 cell line was kindly provided by Dr J. Silvio Gutkind (NIH; Besthesda, MD). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.,), 100 IU/ml penicillin and 100 µg/ml streptomycin, and maintained at 37˚C in a humidified 5% CO 2 atmosphere. Construction of miRNA sponge and transfection. An miR-221/222 sponge was constructed by inserting tandemly arrayed miRNA binding sites into the 3'UTR of a reporter gene encoding destabilized enhanced green fluorescent protein driven by the murine cytomegalovirus promoter. Binding sites contained 3 hsa-miR-221 and hsa-miR-222 antisense sequences complementary to miR-221/222. The miR-221/222 sponge and empty vector were transfected using Lipofectamine ® 3000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol, and the transfection medium was replaced with fresh DMEM containing 10% FBS 6 h later. Following treatment for 48 h, CAL27 and HSC6 cells were divided into 3 groups, including the control, scramble and miR-221/222 sponge, and used for subsequent analysis.
RNA isolation and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total miRNA and mRNA were extracted using the miRNeasy mini kit (Qiagen GmbH, Hilden, Germany) and the RNeasy Micro kit (Qiagen GmbH) according to the manufacturer's protocol. RT-qPCR was performed using the Primescript RT reagent kit (Takara, Otsu, Japan) with U6 and 18S rRNA as the loading controls. For the detection of miR-221/222 and PTEN, the SYBR Green PCR assay (SYBR ® Premix Ex Taq™; Takara) was performed and the primer sequences used were as follows: miR-221 forward, ACA CTC CAG CTG GGA GCT ACA TTG TCT GCT GG and reverse, CTC AAC TGG TGT CGT GGA; miR-222 forward, ACA CTC CAG CTG GGA GCT ACA TCT GGC TAC TG and reverse, CTC AAC TGG TGT CGT GGA; U6 forward, CTC GCT TCG GCA GCA CA and reverse, AAC GCT TCA CGA ATT TGC GT; PTEN forward, TTG TGG TCT GCC AGC TAAA and reverse, CGC TCT ATA CTG CAA ATG CT; 18S rRNA forward, CCT GGA TAC CGC AGC TAG GA and reverse, GCG GCG CAA TAC GAA TGC CCC. The PCR was performed in triplicate consisting of 40 cycles of a denaturation step at 95˚C for 5 sec, annealing at 60˚C for 30 sec and extension at 72˚C for 30 sec after a cycle of a pre-denaturation step at 95˚C for 30 sec on an ABI PRISM ® 7500 Sequence Detector (Applied Biosystems, Foster City, CA, USA). Relative expression levels were calculated using the 2 -ΔΔCq method (24) . 4 cells/chamber) were seeded into the upper chambers in 100 µl serum-free DMEM, while 600 µl DMEM supplemented with 10% FBS was added to the lower chambers. The cells were incubated at 37˚C in a humidified 5% CO 2 atmosphere for 24 h, and the cells and Matrigel in the upper chambers were subsequently discarded. Cells in the lower chamber were fixed with 4% paraformaldehyde solution for 20 min and then stained with 0.05% crystal violet for 15 min, followed by washing with PBS. Images were captured using an inverted microscope and the number of invasive cells was counted.
Western blot analysis.
Flow cytometry. After transfection for 48 h, CAL27 and HSC6 cells were collected in the log phase of growth by centrifugation for 5 min at 1,000 x g and 25˚C, and rinsed with PBS 3 times. The cell apoptosis assay was performed using an Annexin-V-FLUOS Staining kit (Roche Diagnostics GmbH). Cells were resuspended in incubation buffer at a density of 10 6 /ml. Subsequently, 5 µl Annexin V-fluorescein isothiocyanate and 5 µl propidium iodide (PI) were added to the cell suspension according to the manufacturer's protocol. The cells were incubated for 15 min at room temperature in the dark. The stained cells were analyzed by an FC500 flow cytometer (Beckman Coulter, Fullerton, CA, USA).
Statistical analysis. All data are presented as the mean ± SD. The results were determined by Student's t-test using SPSS version 15.0 software (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

miR-221/222 direct targeting of the PTEN mRNA 3'UTR.
To validate whether PTEN is a direct target of miR-221/222, PTEN 3'UTR and mutPTEN 3'UTR luciferase constructs were transfected into into 293T cells with miR-221/222 mimics, mimic negative control (NC), miR-221/222 inhibitor or inhibitor NC. Luciferase activity was detected using a Dual-Luciferase Reporter Assay System. As can be observed in Fig. 1B , the luciferase activity of 293T cells transfected with miR-221/222 and PTEN 3'UTR was reduced when compared with all other treatment groups.
miR-221/222 and PTEN expression in CAL27 and HSC6 cells.
The present study analyzed the expression of miR-221/222 and PTEN by RT-qPCR. miR-221/222 sponge transfection significantly reduced the miR-221/222 levels compared with the control groups (CAL27: miR-221 vs. control, P=0.0063; miR-222 vs. control, P=0.0090; HSC6: miR-221 vs. control, P=0.00072; miR-222 vs. control, P=0.00058) ( Fig. 2A and B) . The bioinformatics analysis predicted that miR-221/222 would regulate the expression of PTEN. The results of the present study showed that in miR-221/222 sponge groups, a notable upregulation of PTEN was observed in CAL27 and HSC6 cells (Fig. 2C and D) .
Determination of PTEN and pAkt expression in CAL27 and HSC6 cells.
To investigate the impact of miR-221/222 on protein expression (Fig. 3) western blot analysis was performed. It was observed that the level of PTEN expression was increased and the expression of pAkt was decreased in miR-221/222 sponge transfected CAL27 and HSC6 cells compared with controls. The data suggest that the expression of PTEN in CAL27 and HSC6 cells was negatively regulated by miR-221/222.
miR-221/222 sponge inhibits CAL27 and HSC6 cell proliferation.
The effect of miR-221/222 on the growth of CAL27 and HSC6 cells was determined using a CCK8 assay. Compared with the control group, the miR-221/222 sponge inhibited CAL27 and HSC6 cell growth (P<0.05 vs. control) (Fig. 4) .
miR-221/222 sponge induces CAL27 and HSC6 cell invasion.
The role of miR-221/222 on cell invasion was further assessed by a Transwell assay. As shown in Fig. 5 , the invasive ability of CAL27 and HSC6 cells that were transfected with the miR-221/222 sponge was significantly reduced when compared with the control groups (P<0.01, P=0.0087 and P=0.00063 vs. control, respectively).
miR-221/222 sponge induces CAL27 and HSC6 cell apoptosis.
To examine the effect of the miR-221/222 sponge on CAL27 and HSC6 cell apoptosis, Annexin V-PI analysis was performed. The results showed that the number of apoptotic cells was significantly increased following treatment with the miR-221/222 sponge, compared with the untreated groups, suggesting that miR-221/222 sponge treatment induced apoptosis (P=0.00024 and P=0.00003 vs. control, respectively) (Fig. 6 ).
Discussion
In previous years, increasing evidence has highlighted the importance of miRNAs in the development and progression of various types of cancer, including OSCC (25) . miRNAs are considered to be novel molecular targets in the diagnosis and treatment of human carcinoma (1) . Abnormal expression of miR-221/222 has been observed and implicated in multiple neoplasms, but to the best of our knowledge the equivalent research into OSCC has not been performed (7, 8, 26) .
PTEN was demonstrated to be a direct target gene of miR-221/222, and the binding sites for miR-221/222 in the PTEN 3'UTR were predicted by bioinformatic analysis. Furthermore, the results of the Dual-Luciferase Reporter Assay confirmed that PTEN was a target gene of miR-221/222. To investigate further, it was necessary to remove miR-221/222 function. This could be achieved through an antisense oligonucleotide inhibitor, genetic knockout or miRNA sponge (10, 11, 27) . In the present study, a miR-221/222 sponge was constructed in order to downregulate the expression of miR-221/222. Results from RT-qPCR confirmed that transfection with the miR-221/222 sponge significantly reduced the miR-221/222 levels compared with the control groups. miRNA sponge technology was initially introduced and verified by Ebert et al (10) through the creation of RNAs containing multiple binding sites complementary to the miRNA of interest, leading to the continuous loss of miRNA function (28, 29) . The sponge is usable in a long-term miRNA knockout experiment, while maintaining an efficiency comparable with knockout by antisense oligonucleotide inhibitors (10) . It is more convenient to use the sponge rather than perform a gene knockout to build miRNA silencing cells or animal models. Additionally, a sponge with common sequences could block a whole miRNA family, which has the same seed regions (10, 12) . Moreover, a sponge can be constructed to work on multiple miRNAs synchronously by connecting different inhibiting sequences of relevant miRNAs in series (10, 12) . It should, however, be noted that the sponge may exhibit inefficient inhibition at excessively high concentrations of miRNA, as the sponge reaches maximum saturation (11) . In previous studies, an miR-221/222 sponge was successfully constructed and its effect in OSCC cells was investigated (12) . In addition to this, the results of the present study demonstrated that the miR-221/222 sponge satisfactorarily inhibited the expression of miR-221/222.
In the present study, it was identified that miR-221/222 regulates OSCC cell proliferation, invasive ability and apoptosis. The results of the present study show that CAL27 and HSC6 cell proliferation and invasive ability was inhibited, and apoptosis was promoted, when miR-221/222 expression was suppressed. Yang et al (26) Previous studies have observed abnormal expression of PTEN in OSCC and that its expression levels were correlated with the degree of carcinoma differentiation (13, 14, 31) . In the present study, it was observed that knockdown of miR-221/222 in CAL27 and HSC6 cells resulted in upregulation of PTEN and downregulation of pAkt. PTEN has been identified as a tumor suppressor and negative regulator of the PI3K/Akt signaling pathway. The PI3K/Akt signaling pathway has been identified as an oncogenic pathway and regulator of numerous cellular processes, including proliferation, cell cycle, migration, invasion and apoptosis (32, 33) . The results of the present study suggest that OSCC cell proliferation, invasion and apoptosis are associated with expression of PTEN. Activated PTEN dephosphorylates phosphatidylinositol 3,4,5-trisphosphate to give phosphatidylinositol 4,5-bisphosphate, and inhibits the phosphorylation status of Akt, which results in decreased oncogenic activity (34) . Akt is a key molecule in the PI3K signaling pathway, and the activity of Akt is tightly regulated by its phosphorylation status (33) . pAkt is activated in various types of OSCC and has been confirmed to promote cell proliferation, invasion, migration and reduce apoptosis (23, 35) . Research has shown that loss of PTEN function may be a factor leading to Akt signaling pathway activation and is consistent with the results of the present study (14, 36) .
In the present study, it was demonstrated that PTEN is a crucial functional target of miR-221/222 in OSCC cells. When miR-221/222 is inhibited by the miR-221/222 sponge, the results suggest that miR-221/222 has a regulatory function in OSCC cell proliferation and invasion. Through the targeting of PTEN, the PI3K/Akt signaling pathway may also be involved. The results of the present study indicate a potential novel therapy for OSCC.
